Navigation Links
TriMix-gel vs Viagra, Levitra, Cialis Data to Be Presented at AUA
Date:4/30/2008

CHERRY HILL, N.J., April 30 /PRNewswire/ -- T.J. Harkins, President of TriMix Laboratories LLC, announced today that an abstract related to erectile dysfunction product, TriMix-gel(TM), will be presented at a moderated session of the American Urologic Association (AUA) annual meeting, May 20, 2008 in Orlando, FL. The study is entitled STUDIES WITH TRIMIX GEL IN MEN WHO FAILED PHOSPHODIESTERASE INHIBITORS.

The abstract evaluates TriMix-gel as an alternative for erectile dysfunction (ED) patients who failed treatment on oral tablets such as Viagra(R), Levitra(R) or Cialis(R), known as phosphodiesterase type 5 inhibitors (PDE5). The research was completed in Cherry Hill, New Jersey by Urologist Joel L. Marmar, MD and associates.

A test group of 42 patients who failed treatment with PDE5 oral agents were evaluated as to Erection Hardness Scores (EHS) and penile rigidity. The patients had various co-morbidities including high blood pressure, high cholesterol, diabetes and radical prostatectomy.

Statistically Significant Greater Erection Hardness Scores (EHS)

Dr. Marmar stated "The conclusions of the study indicate TriMix-gel may have several advantages over oral agents and intracavernous injections. Administration of the medicine is painless. Even without stimulation by a partner or erotic videos, TriMix-gel demonstrated statistically significant greater Erection Hardness Scores by the study group versus oral agents."

The abstract has been published in the Journal of Urology Supplement, J. Urol. 179 (4): 431, 2008. For more information on TriMix-gel visit http://www.trimixgel.com

TriMix-gel is prepared by a compounding pharmacy. The profession of pharmacy has always been based on the patient-physician-pharmacist relationship, known as the "Triad". Through this "Triad" relationship, patient needs are determined by a physician, who chooses a treatment regimen that may include a compounded medication. Physicians often prescribe compounded medications for various reasons, such as when a patient cannot ingest a medication in its available form. A pharmacist can prepare the medication in cream, liquid, gel or other form that the patient can more easily take.

This press release contains forward looking statements. These statements involve risks and uncertainties which may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed and actual results may differ materially. Ingredients in TriMix- gel(TM) are FDA approved but TriMix-gel(TM) is a custom compound made in a pharmacy and therefore has not been approved by the FDA for treatment of ED. TriMix-gel(TM) requires a valid prescription from a physician. You should discuss the risks and side effects associated with this drug with your physician. For more information on TriMix-gel visit http://www.trimixgel.com Before taking any action, consult your physician.

Contact

T.J. Harkins

TriMix Laboratories

Cherry Hill, NJ

856-428-7008

http://www.trimix-gel.com


'/>"/>
SOURCE TriMix Laboratories LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
2. Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
3. MLM Expert and Start-Up Specialist Jim Clayton Joins Healthy Coffee USA
4. Agilysys Hosts IBM Specialist at Health Care Webinar Offering Data Storage Solutions
5. SLCH Brings Infertility Specialist to Region
6. Specialists in drug discovery and development convene
7. Debut issue of Foot & Ankle Specialist
8. Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources
9. Cleveland Clinic Recruits World Renowned Heart Rhythm Specialist to Direct Electrophysiology
10. Georgia Cancer Specialists to Sponsor Sixth Annual Totes 2 Tots Suitcase Drive for Foster Children
11. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... WhoHaha , a digital media company dedicated to creating and delivering female-centric, comedic content, ... series that uses humor to highlight ways to improve heart health and overall well-being. ... movement, which is designed to inspire all Americans to make small changes that add ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at the ... internship in internal medicine at the Emory University and dermatology training at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for patients with sleep apnea and TMJ disorders. These conditions are quite common ... Dr. Rassouli provides personalized care to reduce the risk of these consequences and ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... asset protection and financial planning services to communities throughout eastern Georgia, is embarking ... against heart disease. , Heart disease kills more Americans every year than anything ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative ... Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries from ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor ... global anti-obesity drugs market is expected to grow at a ... and CAGR of 38.7% in the second half of the forecast ... 32.8% from 2016 to 2027. The market is estimated at $1,058 ... 2027. ...
(Date:1/19/2017)... 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... in the treatment of non-melanoma skin cancers and ... radiation therapy, today announced that it will report ... results on Thursday, February 2, 2017 after the market ... conference call with the investment community on Thursday, February ...
(Date:1/19/2017)... New Review of Safinamide ... Symptoms and Motor Complications in Mid- to Late-stage ... ... C Warren Olanow ... 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published ...
Breaking Medicine Technology: